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Abstract
Extracellular DNA trap formation is a cellular function of neutrophils, eosinophils, and basophils that facilitates the
immobilization and killing of invading microorganisms in the extracellular milieu. To form extracellular traps,
granulocytes release a scaffold consisting of mitochondrial DNA in association with granule proteins. As we
understand more about the molecular mechanism for the formation of extracellular DNA traps, the in vivo function of
this phenomenon under pathological conditions remains an enigma. In this article, we critically review the literature to
summarize the evidence for extracellular DNA trap formation under in vivo conditions. Extracellular DNA traps have
not only been detected in infectious diseases but also in chronic inflammatory diseases, as well as in cancer. While on
the one hand, extracellular DNA traps clearly exhibit an important function in host defense, it appears that they can
also contribute to the maintenance of inflammation and metastasis, suggesting that they may represent an interesting
drug target for such pathological conditions.
Facts
● The demonstration of extracellular DNA traps
in vivo requires sections of affected tissues, which
are to be investigated with special staining
techniques. These structures are seen in multiple
inflammatory and cancer diseases.
● Measurements of cell-free (cf) DNA either alone or
as complexes with granules or other cationic
proteins, do not prove the in vivo presence of
extracellular traps.
● Although neutrophil extracellular traps (NETs)
contribute to pathogen clearance, excessive NET
formation promotes inflammation and tissue damage.
● There is experimental evidence that NETs can
contribute to metastasis.
● Eosinophil extracellular traps (EETs) can bind and kill
bacteria. They are often seen in areas of epithelial
barrier defects.
Open questions
● Under which pathological conditions are
extracellular DNA traps suitable drug targets?
● Is there a simple biomarker that reflects extracellular
DNA trap formation?
● What is the contribution of extracellular microbe
killing compared to intracellular killing following
phagocytosis?
● The mechanism of DNA trap formation is unknown.
Introduction
Since their discovery, neutrophil extracellular traps
(NETs) have been implicated as playing a role in host
defense since they can disarm and kill bacteria extra-
cellularly1. Studies aiming at unraveling the underlying
mechanisms of NET formation demonstrated a require-
ment for the production of reactive oxygen species
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(ROS)2–5. ROS induces actin and tubulin glutathionyla-
tion, which is tightly regulated by glutaredoxin 1 (Grx1),
an enzyme required for deglutathionylation of actin and
microtubulin. Thus, an intact cytoskeleton is required for
the formation of NETs6. Moreover, optic atrophy 1
(OPA1), one of five GTPase dynamin family members,
known to play a role in mitochondrial (mt) fusion, has
recently been shown to be required for ATP production
through glycolysis in neutrophils. If increases in ATP
production are blocked, the assembly of the microtubule
network and thus the formation of NETs do not occur7.
ATP and ATP channel pannexin 1 (Panx1) contribute to
NET formation and may represent therapeutic targets8.
In addition to neutrophils, other granulocyte types can
also form extracellular DNA traps, such as eosinophils
(eosinophil extracellular traps, EETs)9,10 and basophils
(basophil extracellular traps, BETs)11. Over the last dec-
ade, a number of stimuli, microbial and noninfectious
stimuli, able to induce extracellular trap formation have
been identified12–16. It should be noted that there is an
ongoing scientific dispute whether NET formation
requires cell death or not17–20. In this article, we focus on
the current evidence of DNA traps under in vivo condi-
tions and discuss their possible role(s) in the disease
pathogenesis. These studies suggest that extracellular
DNA traps exert effects beyond host defense, including
allergic diseases, cancer, vascular diseases, and coagula-
tion. This assumption is best supported by the observa-
tion that besides granulocytes, activated T cells, B cells,
NK cells, and monocytes are also able to release mtDNA
forming extracellular web-like structures, but the latter
are devoid of bactericidal proteins. However, these
structures containing mtDNA are able to provoke a rapid
type I interferon (IFN-I) production in peripheral blood
mononuclear cells, suggesting that lymphocytes and
monocytes use mtDNA as a rapid signaling molecule to
communicate danger21. Interestingly, mtDNA being
enriched in unmethylated cytosine-phosphate-guanine
(CpG) dinucleotide motifs similar to bacterial and viral
DNA could provoke IL-10 secretion21,22, and transform-
ing growth factor beta (TGF-β) release23. IL-10 is known
to be an anti-inflammatory cytokine24, and TGF-β med-
iates the suppression of macrophage-directed inflamma-
tion, reducing TNF-α release25. Combination of anti-
inflammatory and regulatory cytokines could dampen the
excess inflammation (Fig. 1a).
The verification of DNA traps in vivo is challenging, as
it requires special technical skills26,27. Measuring DNA
concentrations in the absence or presence of granule
proteins is clearly insufficient for concluding the presence
of NETs or EETs, but in combination with (immuno)-
histological investigations (Fig. 2), these techniques might
be used for possible quantification. For example,
increased DNA concentrations can occur as a
consequence of a lytic granulocyte death (Fig. 1b), but also
as a result of tissue damage that is a frequent phenom-
enon with inflammatory responses. Moreover, in contrast
to in vitro conditions, the exact type of stimulus, its
dosage and exposure time cannot be assessed under
in vivo condition. With these limitations in mind, the
reader may understand that the interpretation of the
available studies is difficult and it is thus impossible,
owing to space limitations, to critically evaluate all cited
published findings. We sometimes just reflect the cited
work, as it was reported by the original authors. Never-
theless, we often also mention a note of caution.
The formation of extracellular DNA traps in
infectious diseases
The formation of extracellular DNA traps by neu-
trophils, eosinophils, and basophils, but also lymphocytes,
has been observed in various infections of humans, mice,
and additional species. Viruses, bacteria, fungi, and
parasites have been shown to induce the generation of
extracellular DNA traps, which can entrap and even kill
the microbes through the action of associated toxic
proteins.
NETs and EETs in bacterial infections
In the bronchial aspirates from patients with acute
respiratory infections, bacteria and NETs were visualized
using Gram stain and immunostaining. Neutrophils
abundantly released NETs, and the NET length that was
highest during acute infection and shortened with the
recovery, correlated with clinical and laboratory signs of
infection, as well as inflammatory cytokine levels in
serum28. In an animal model of acute respiratory distress
syndrome, in which neutrophil infiltration promotes tis-
sue injury and sustained inflammation, the content of cf
DNA in bronchoalveolar fluid was significantly higher in
mice injected with LPS from Escherichia coli as compared
with controls, and was decreased by glutamine treat-
ment29. It should be noted, however, that in these two
studies, NET formation and DNA concentrations were
analyzed ex vivo using BAL fluids. To compensate for this
shortcoming, lung tissue biopsies should be stained for
NET detection in order to confirm the ex vivo data. In
addition, cf DNA as well as granule and histone proteins
are often quantified as “in vivo NET formation”30. Clearly,
it is impossible to distinguish whether the released DNA/
protein complexes are owing to NET formation or neu-
trophil death31,32, the latter of which was reported to
occur under in vivo conditions more than 50 years
ago33,34.
Genetically modified mice have been used to determine
the role of specific proteins for NET formation under
in vivo conditions. For instance, the role of peptidylargi-
nine deiminase 4 (PAD4), an enzyme that catalyzes
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citrullination of histones, has been intensively studied in
association with NET formation. Several reports have
argued that PAD4 activity is essential for NET forma-
tion14,35–41, and contrary others disputed that PAD4 is
not crucial for NET formation or the antimicrobial
defense mechanism in vivo42–45. Specifically, NET for-
mation in Klebsiella pneumonia-induced pneumonia was
investigated showing NET-like structures surrounding
Klebsiella bacteria at sites of immune infiltration in both
Pad4−/− and Pad4+/+ mice. Moreover, both groups
showed similar bacterial growth, lung inflammation, and
organ injury. In conclusion, these data argue against a
major role for PAD4 in NET formation, host defense, or
organ injury during pneumonia-derived sepsis44.
Cystic fibrosis (CF) is characterized by a chronic
inflammation of the airways associated with bacterial
colonization. It has been reported that CF neutrophils
have a pro-survival phenotype that allows increased NET
production, which can in turn induce inflammation46.
However, it should be noted that this conclusion is based
mainly on ex vivo data. Both mucoid and non-mucoid
Pseudomonas aeruginosa strains were demonstrated to
activate neutrophils to generate NETs, a process that is
promoted by macrophage migration inhibitory factor
(MIF)47. Moreover, MIF protein levels in the blood of CF
patients were significantly elevated compared with MIF
levels in pooled human serum from healthy controls and
negatively correlated with lung function47. On the other
hand, the development of mucoidy (i.e., increased alginate
production) is an acquired Pseudomonas aeruginosa
virulence factor that is closely associated with increased
severity of CF. The conversion to a mucoid phenotype
coincided with a decline in susceptibility to NETs, raising
the possibility that increased alginate production decrea-
ses interactions with NETs, or otherwise interferes with
killing by NET-associated granule proteins48.
Fig. 1 Modulation of the immune system by neutrophil extracellular trap (NET) formation and cytolysis. a NET formation: In response to
physiological stimuli or bacterial infection, viable neutrophils generate NETs in a NADPH oxidase-dependent manner. NETs consist of a mitochondrial
(mt)DNA scaffold, which binds neutrophil granule proteins such as neutrophil elastase (NE) and myeloperoxidase (MPO)4,6,7,144,152. If the source of
infection/stimulation persists, the released mtDNA, having similarity to viral and bacterial DNA (enriched in unmethylated CpG motifs), acts as a
danger signal and triggers cytokine production for a protective and regulated immune response7,55. b Cytolysis: Under pathological conditions, such
as the persistent presence of foreign antigens104, “too large to be trapped antigens”, such as fungal hyphae60,61, strong adhesion receptor
activation153–155, presence of monosodium urate (MSU)88, or phorbol-myristate-acetate (PMA) stimulation2,12, results in an excess of reactive oxygen
species (ROS), leading to neutrophil cytolysis. Similarly, excessive increases in intracellular calcium [Ca2+]i by ionomycin results in non-apoptotic
neutrophil death12,81. Certain bacteria are also capable of causing neutrophil cytolysis by releasing pore-forming toxins that can directly cause plasma
cell and nuclear membrane permeabilization156–159. The externalized cell exudates containing cytoplasmic and nuclear proteins together with
damaged nuclear DNA can act as so-called self-antigens (Self-Ag) that are recognized and processed by antigen-presenting cells (APCs). Activated
APCs produce pro-inflammatory cytokines and stimulate autoreactive T and B cells, leading to autoantibody production. The circulating
autoantibodies such as anti-damaged-DNA/RNA ribonucleoprotein antibody immune complexes (RNP-ICs-Ab) can further activate neutrophils,
including NET formation (not shown)13,73,74, leading to vicious cycle of chronic inflammation in genetically susceptible individuals68,74, causing
autoimmune diseases such as systemic lupus erythematous (SLE).
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Staphylococcus aureus may cause serious infections, in
particular when complicated by bacteremia and sepsis,
and present a common health problem worldwide. In
order to unravel the mechanism of organ damage, a
mouse model was applied. Intravenous infection with
multi-resistant Staphylococcus aureus led to a rapid
sequestration of the bacteria to the liver, neutrophil
recruitment and NET formation within the liver sinu-
soids, and subsequent liver damage14. As neutrophil
elastase (NE), a component of NETs, was demonstrated to
be enzymatically active and NE staining observed in areas
adjacent to focal necrosis, the authors concluded that
NET formation largely contributes to liver damage14.
However, the authors also observed that destroying NETs
by DNase treatment only partly reduced tissue injury,
leaving some doubt about whether NETs are solely
responsible for the immunopathology in this
experimental model.
In addition, DNases are expressed by many Gram-
positive bacterial pathogens, but their role in virulence is
not clear. Expression of a surface endonuclease encoded
by EndA is a common feature of many pneumococcal
Fig. 2 Detection of extracellular traps in tissues. a Eosinophil extracellular traps (EETs) in mouse and human tissues. EETs consisting of DNA (red)
and eosinophil peroxidase (EPX) (green) are depicted in 12-week-infected Citrobacter rodentium-infected mouse colon tissues55 (upper panel) and
cutaneous Larva migrans-infested human skin tissue26 (lower panel). b Neutrophil extracellular traps in mouse and human tissues. NETs consisting of
DNA (red) and neutrophil elastase (green) are shown in overnight infected Pseudomonas aeruginosa-mouse lung tissue7 (upper panel), and in human
lung tissue from patients with bronchial asthma97 (lower panel). Extracellular traps are indicated by white arrows. Bars, 10 μm.
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strains. EndA nuclease allows pneumococci to degrade the
DNA scaffold of NETs and escape. Escaping NETs pro-
motes spreading of pneumococci from the upper airways
to the lungs and from the lungs into the blood stream
during pneumonia49. Bacterial release of DNase and
phosphatases contribute to defense against NET-
mediated killing of Pseudomonas aeruginosa, high-
lighting the role of manipulating enzymes in combating
NETs by microorganisms50. In addition, the pneumo-
coccal polysaccharide capsule protects from NET trap-
ping, but is not required for resistance to NET-mediated
killing (Fig. 3)51.
In piglets infected with Streptococcus suis causing
meningitis, NETs that consisted of DNA and associated
NE have been detected in the cerebrospinal fluid (CSF)52.
During pneumococcal meningitis, NETs in the central
nervous system have been reported to hinder bacterial
clearance. NETs were present in the CSF of patients with
pneumococcal meningitis, but absent in other forms of
meningitis with neutrophil influx in the CSF53.
Pneumococci-induced NET formation in the CSF of
infected rats could be cleared upon intravenous applica-
tion of DNase I resulting in a disruption of NETs in the
CSF followed by bacterial clearance, suggesting that NETs
may contribute to pneumococcal meningitis pathogenesis
in vivo53.
The formation of NETs has also been observed at
cutaneous tick bite sites. Here, NETs have the potential to
entrap and kill Borrelia burgdorferi, spirochetes causing
Lyme disease. NETs have been observed in the upper and
deep dermis after 3 and 5 days, respectively, that was not
affected by either tick saliva or nucleases derived from
these bacteria54.
Intestinal eosinophil infiltration and deposition of EETs,
which were shown to be able to kill bacteria, were pro-
tective against microbial sepsis after cecal ligation in IL-5-
transgenic, but not wild-type mice9. Moreover, infection
with Citrobacter rodentium resulted in increased fre-
quencies and activation of eosinophils and low bacterial
load in the colon of wild-type mice, while eosinophil-
deficient mice exhibited a high bacterial load despite the
infiltration of neutrophils, Th1, and Th17 cells55. In this
in vivo model showing that Citrobacter rodentium
induced formation of EETs with bactericidal effects, and
that EETs are present in the colon of infected mice pro-
vide further evidence for a role of EETs in controlling
bacterial infection55.
NETs in viral, fungal, and parasitic infections
Influenza virus infection creates a highly pro-
inflammatory lung environment and neutrophils, which
are recruited to the lungs, encounter inflammatory med-
iators that can trigger NET formation42. Upon challenge
of mice with lethal doses of influenza virus, NETs were
found in infected lungs in the alveoli, and DNA fibers
associated with matrix metallopeptidase (MMP)-9 and
histones H2B were directed toward the alveolar epithe-
lium and small blood vessels in areas with hemorrhagic
Fig. 3 Mechanisms of microorganisms for escape from extracellular traps. a Extracellular traps consisting of a DNA scaffold and granule proteins
entrap and kill microorganisms6,7,14,152. Certain pathogens have developed properties for escaping the physical entrapment by (b) encapsulation of
bacteria to shield against traps51 or (c) release of endonucleases to degrade the extracellular DNA scaffold leading to less efficient killing of
bacteria49,50.
Yousefi et al. Cell Death and Disease          (2020) 11:300 Page 5 of 15
Official journal of the Cell Death Differentiation Association
lesions, indicating that there exists a contribution by
NETs to alveolar–capillary damage56. Respiratory syncy-
tial virus (RSV) may cause a severe lower respiratory tract
disease (LRTD) in young children that is characterized by
an extensive neutrophil accumulation in the lungs and
occlusion of small airways by DNA-rich mucus plugs. In
vitro, NETs were shown to capture RSV, and thus prevent
its binding to target cells57. NET formation was also
observed in the airways and lungs of children with severe
RSV-LTRD. However, their effects in vivo seem double
edged as demonstrated in a bovine model of RSV-LTRD
revealing NET formation either with or without captured
viral antigen in the dense plugs that finally occluded the
airways57. Furthermore, double-stranded DNA (dsDNA)
released by NETs recapitulate and promote rhinovirus-
induced type-2 allergic immune responses and asthma
exacerbation. Thus, NETs and their associated extra-
cellular dsDNA contribute to the pathogenesis and may
represent potential therapeutic targets of rhinovirus-
induced asthma exacerbations58.
Candida albicans, a eukaryotic pathogen that is a
common cause of fungal infections in humans, particu-
larly in immunocompromised individuals, induces neu-
trophils to form NETs that capture and kill both hyphal
and yeast form cells, for which NET-associated granule
proteins are essential59. Further, it has been postulated
that neutrophil responses, either phagocytosis or NET
formation, are regulated by the microbial size indepen-
dent of fungal surface molecule expression or enzymatic
activity in vitro60,61. Correspondingly, NET release in the
lungs of mice occurred upon exposure to wild-type
Candida albicans that form both yeast and hyphae,
whereas the yeast-locked hgc1Δ mutant, that cannot form
hyphae, failed to induce NETs, and myeloperoxidase
(MPO)-deficient mice able to kill via phagocytosis cleared
the hgc1Δ yeast-locked strain, but not wild-type Candida
albicans61. These in vivo observations indicate that NETs
were not required for the clearance of yeasts, but for
controlling hyphae.
In mice infected with larvae of Strongyloides stercoralis,
an increase of extracellular DNA in the peritoneal exu-
dates was observed 3 h after infection. The authors argued
that this observation would be suggestive evidence for
NET formation, although direct proof under in vivo
conditions was not provided. However, the authors
demonstrated in vitro experiments, suggesting that larvae
of Strongyloides stercoralis induce the release of extra-
cellular DNA forming clot-like structures ensnaring live
larvae62. In an experimental setting using human neu-
trophils and macrophages in the presence of complement,
both cells collaborated and killed the larvae in a manner
requiring NET formation. Interestingly, when mouse cells
were used, killing of larvae occurred independent of NET
formation62.
The protozoan Toxoplasma gondii induced NET for-
mation by mouse and human neutrophils with parasite
entrapment and killing in vitro. NET formation was also
shown in vivo in a mouse intranasal infection model63. On
the other hand, although infection with Leishmania
mexicana resulted in NETs entrapping parasites in the
tissue of infected mice, in vitro experiments revealed that
the induced NETs were unable to kill this protozoan64.
NET formation in onchocerciasis (river blindness), a
helminth infection, is induced by the release of the bac-
terial endosymbiont, Wolbachia, and not directly by the
filarial nematode Onchocerca volvulus. The onchocerco-
mata (subcutaneous nodules) of patients contain worms
positive for Wolbachia and exhibited high numbers of
NETs. NETs were found in zones adjacent to the nema-
tode cuticle, whereas nodules derived from patients
treated with the anti-Wolbachia drugs, doxycycline+
ivermectin were depleted for Wolbachia and lacked
NETs65. More recently it was reported that NETs would
drive inflammation in malaria by releasing soluble NET
components to facilitate parasite sequestration and tissue
destruction, and inhibition of NETs as a treatment strat-
egy in vascular infections was recommended16.
The formation of extracellular DNA traps in
autoimmune and autoinflammatory diseases
The formation of NETs has been demonstrated in
several autoimmune and autoinflammatory diseases. In
most studies, NETs appear to be part of the pathological
process. Some of the proposed mechanisms are
discussed below.
NETs in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is considered to be a
prototypic systemic autoimmune disease and is character-
ized by loss of tolerance to self-antigens, abnormal T- and
B-cell responses, and autoantibody production66–70. Its
pathogenesis involves defective clearance of immune com-
plexes and debris containing nucleic acids, excessive innate
immune activation involving Toll-like receptors (TLR) and
type I interferons, as well as aberrant lymphocyte activa-
tion71. Upon stimulation with antimicrobial72 or anti-
ribonucleoprotein (RNP) antibodies13,73,74, neutrophils
from SLE patients have been shown to release self-DNA
associated with antimicrobial peptides able to trigger innate
plasmocytoid dendritic cell (pDC) activation via TLR9 to
produce IFN-Ι (Fig. 1). The immune complex-mediated
glomerulonephritis in SLE has been associated with a non-
lytic extrusion of NETs concomitant with clustering of
neutrophils within minutes that have immunogenic prop-
erties, including enrichment for high mobility group box
protein 1 (HMGB1), oxidized mtDNA, and immune com-
plex (ICx) formation13,73,75. By applying immuno-
fluorescence staining, NETs composed of mtDNA and
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MPO have been detected in affected glomeruli66. Moreover,
the proportion of glomeruli infiltrated by netting neu-
trophils correlates with lupus nephritis activity. The fact
that NETs containing MPO as well as intact neutrophils are
present in the dermis and dermal blood vessels of cuta-
neous lupus lesions suggests that enhanced NET formation
occurs in vivo in affected organs of SLE patients76. SLE
patients were found to develop autoantibodies to both the
self-DNA and antimicrobial peptides present in NETs,
indicating that these complexes serve as autoantigens to
trigger B-cell activation. NETs containing cathelicidin LL-
37–DNA complexes can directly trigger human memory B
cells and induce the production of anti-neutrophil and anti-
LL-37 antibodies in B cells of SLE patients (Fig. 1)77.
The timely removal of NETs seems crucial to avoid
presentation of self-antigens. For instance, sera of a subset
of SLE patients failed to properly clear NETs due to the
presence of DNase I inhibitors or and anti-NET anti-
bodies preventing DNase I access to NETs. The resulting
impaired NET degradation correlated with renal disease78.
Moreover, NETs derived from SLE neutrophils exhibit
lower ubiquitin concentrations and a different ubiquiti-
nated protein pattern compared with healthy controls79.
The presence of ubiquitinated MPO in NETs and anti-
ubiquitinated MPO antibodies in sera of SLE patients
correlated with disease severity, suggesting a role for the
ubiquitination status of NETs in the pathogenesis of
SLE79.
A mitochondrial ROS scavenger was administered to
MRL/lpr (lupus-prone mice) resulting in reduced mtDNA
release and suppressed lupus-like disease13. Metformin,
which in vitro decreased the number of mtDNA copies in
NETs, significantly reduced the disease activity in SLE
patients when given as an add-on therapy compared with
conventional therapy alone66. Moreover, inhibition of
PAD4 was reported to reduce the severity of SLE in an
experimental mouse model by reducing histone hyperci-
trullination and self-nucleosome antibodies38,80. There-
fore, PAD4 has been suggested as a promising drug target,
and novel PAD4 inhibitors have been developed37–39.
However, a pharmacological approach to inhibit PAD4 in
a human serum transfer model of SLE failed to ameliorate
end-organ damage and concluded that PAD4 does not
appear to be crucial for SLE pathogenesis45,81.
NETs in vasculitis, rheumatoid arthritis, and psoriasis
NETs have also been implicated in the pathogenesis of
small vessel vasculitis (SVV) leading to inflammation and
destruction of small-sized blood vessels and capillaries.
Upon stimulation with anti-neutrophil autoantibodies
(ANCAs), neutrophils have been shown to release NETs
that contain autoantigens, such as proteinase-3 (PR3) and
MPO82. On the other hand, NETs with their components
mtDNA, PR3, and MPO have been shown to be taken up
by myeloid dendritic cells (mDC), significantly inducing
the production of anti-neutrophil cytoplasmic auto-
antibodies (ANCA) and anti-dsDNA autoantibodies in
mice immunized with NET-loaded mDC83. Therefore,
both NET-induced autoimmunity as well as
autoantibody-mediated NET formation seem to represent
a vicious circle in disease pathogenesis. Similarly, drug-
induced formation of NETs enriched in NE serving as
auto-antigen, together with the release of B-cell activating
factor (BAFF) resulting in B-cell activation, and the pro-
duction of ANCA directed against NE that further
enhance NET formation, have been assumed to be
pathogenic mechanisms in cocaine and levamisole-
associated autoimmunity84. A role for NETs in ANCA-
associated vasculitis is also suggested by the observation
that excessive NET formation correlated with disease
exacerbation85.
Increased NET formation has also been associated with
rheumatoid arthritis (RA). In a mouse model of collagen-
induced arthritis (CIA), injecting chloramidine (Cl-ami-
dine), which inhibits PAD4-mediated hypercitrullination,
significantly reduced NET release and attenuated clinical
disease activity. NETs apparently induced the expansion
of Th1 pathogenic cells through maturation of dendritic
cells and production of IFN-γ86. Therefore, analogous to
SLE, NETs from RA patients may exhibit antigenic
properties, but may also be recognized by autoantibodies,
namely anti-citrullinated antibodies (ACPA)87. On the
other hand, NETs may promote the resolution of neu-
trophilic inflammation by degrading cytokines and che-
mokines and disturbing neutrophil recruitment and
activation88.
NET-like DNA formations have been detected asso-
ciated with MPO and IL-17 in the epidermis, particularly
in Monro’s microabscesses, and associated with IL-17 and
LL-37 in the dermis89. However, the observations that the
morphology of the NETs varied and most of the neu-
trophils in Monro’s microabscesses had altered nuclear
morphology, suggested that the DNA release was at least
partially the result of cell death17,89.
EETs and NETs in bullous pemphigoid
Bullous pemphigoid (BP) is an autoimmune blistering
skin disease characterized by an activation of autoreactive
B and T cells, the production of pathogenetically relevant
autoantibodies directed against the hemidesmosomal
proteins BP180 and BP230, and a prominent eosinophil
infiltration in the skin90. It has been shown that in pre-
bullous lesions, a small subgroup of eosinophils have
formed EETs consisting of mtDNA associated with eosi-
nophil granular proteins26. Some of these EET were
directed against the dermal–epidermal junction, the site
where blister formation occurs26. Thymic stromal lym-
phopoietin (TSLP) has been identified as a cytokine-
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stimulating eosinophils to form EETs, an observation that
might be relevant for BP since TSLP is expressed in the
epidermis and eosinophils infiltrating BP lesions express
the TSLP receptor10. In an ex vivo skin model, eosinophils
stimulated with IL-5 in the presence of BP serum caused a
dermal–epidermal splitting resembling BP. This splitting
was significantly decreased upon adding DNase I, sug-
gesting that EET formation plays at least a partial role90.
These observations make eosinophils interesting targets
for therapy91. A recent study reported the presence of
NETs at sites of blister formation in BP that decreased
with time following treatment in patients undergoing
remission92.
NETs in autoinflammatory diseases
Autoinflammatory diseases manifest as recurrent fevers,
various forms of systemic inflammation or sterile skin,
bone, and joint inflammation without prominent fever,
but involving myeloid cells that lack the stigmata of
classical autoimmune diseases, such as high-titer auto-
antibodies or antigen-specific T cells93. Familial Medi-
terranean fever (FMF) is characterized by neutrophilia
and neutrophil infiltration in affected tissues during
inflammatory attacks induced by physical or psychological
stress. In vitro, the amounts of NETs consisting of DNA
associated with NE and interleukin (IL)-1β, released by
PMNs isolated from FMF patients during attack were
significantly higher compared with those in remission,
when PMNs were resistant to stimuli usually inducing
NET formation94. Abundant infiltrates of neutrophils
forming NETs have been reported in Schnitzler syn-
drome, defined by recurrent urticarial rash, monoclonal
gammopathy, and systemic inflammation95. Flares of
sterile arthritis with neutrophil infiltrate and the over-
production of IL-1β are the main features of pyogenic
arthritis, pyoderma gangrenosum and acne (PAPA) syn-
drome. NETs have been identified in the skin lesions of a
patient with active PAPA syndrome in a milieu char-
acterized by IL-1β, IL-8, and IL-17A expression, but not
in skin samples from a patient with no active skin
lesions96. In vitro, serum of PAPA patients induced NET
formation by neutrophils from healthy donors that could
be blocked by the IL-1 receptor antagonist anakinra,
suggesting that IL-1β contributes to the enhanced NET
formation in PAPA96.
The formation of extracellular DNA traps in
eosinophilic diseases
The formation of EETs has been demonstrated in sev-
eral eosinophilic diseases. In most studies, the extent of
DNA trap formation correlated with disease severity. On
the other hand, bacterial killing by DNA traps appears to
be an important innate immune mechanism in case of the
presence of a disease-promoting and/or inflammation-
induced epithelial barrier defect.
EETs in asthma and rhinosinusitis
Bronchial asthma is a heterogeneous inflammatory airway
disorder that involves eosinophilic and non-eosinophilic,
including neutrophilic, phenotypes. In bronchial biopsies,
EETs consisting of a mtDNA scaffold co-localizing with
MBP were seen in all asthma patients, and their number
correlated with the number of eosinophils97. A subgroup of
patients expressed a high level of neutrophils and NETs, in
which the extracellular mtDNA was associated with NE97.
In an animal model of asthma, the treatment with deox-
yribonuclease, which cleaves extracellular DNA, resulted in
an improvement of airway resistance and abolished extra-
cellular DNA content in BALF as well as goblet cell
hyperplasia98. Peripheral blood eosinophils from patients
with severe eosinophilic asthma (SEA) may be more acti-
vated to produce EETs than those from patients with non-
severe asthma (NSA), which further induces inflammation
in asthmatic airways99. Surfactant protein-D (SP-D), an
epithelial cell product of the airways, is a critical immune
regulatory molecule with a multimeric structure susceptible
to oxidative modifications. We have demonstrated that SP-
D directly binds to the eosinophil membrane, inhibits EET
formation, and reduces asthma exacerbations100. NETs
have also been visualized in induced sputum from patients
with asthma and COPD, which compared with control
sputum, exhibited higher levels of extracellular DNA and
other NET components, such as cathelicidin LL-37, alpha-
defensin 1–3, NE, IL-1β, and CXCL8 correlating with
decreased lung function101. In stable COPD patients,
extensive NET formation was observed in all sputum
samples irrespective of purulence or smoking status102,103.
Moreover, the presence of NETs is associated with disease
severity and microbiota diversity in patients with COPD104.
In chronic rhinosinusitis with nasal polyps that is
characterized by Th2-biased eosinophilic inflammation,
about 8.8% of tissue eosinophils exhibited EETs corre-
lating with IL-5 and periostin tissue levels and coloniza-
tion with Staphylococcus aureus (S. aureus)105. In an
ex vivo human mucosal disease tissue model, transe-
pithelial migration at sites of epithelial defects and mas-
sive EET formation of eosinophils to entrap S. aureus has
been demonstrated105. These observations, together with
the finding that S. aureus can directly induce EET for-
mation, suggested that, in case of epithelial barrier defects,
eosinophils are part of the innate immune response for
avoiding the invasion by bacteria10,105. In a subsequent
study, it was demonstrated that EETs, but not NETs, were
detected at various degrees in all tissue specimens of nasal
polyps or ethmoid tissues obtained by endoscopic sinus
surgery for chronic rhinosinusitis. The number of EETs
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correlated with that of tissue eosinophils, blood eosino-
philia, severity and decreased olfactory function, regard-
less of the presence of nasal polyps, concomitant asthma
or atopy106.
EETs in acute dermatitis responses and eosinophilic
esophagitis
When specimens of various eosinophilic skin diseases
were examined, EETs could be detected in atopy patch
test-induced lesions, but not in biopsies from atopic
dermatitis or in positive patch test reactions of patients
with allergic contact dermatitis, suggesting that EET for-
mation occurs as an acute response to allergens26.
Induced lesions in a patient with bullous delayed-pressure
urticaria showed a marked infiltration of eosinophils, of
which >80% formed extracellular DNA traps, suggesting a
pathogenic role of eosinophils and EETs107.
In eosinophilic esophagitis, EET formation occurred
frequently, as it was detected in all tissue samples ana-
lyzed, and correlated with the number of tissue eosi-
nophils108. Moreover, there was evidence for epithelial
barrier defects, e.g., decreased filaggrin and protease
inhibitor LEKTI expression, while LEKTI inversely
correlated with the number of EETs108. These findings
imply a role for eosinophils in protecting the host
against invading pathogens in case of a disrupted epi-
thelial barrier by generating EETs and thus establishing
a second barrier.
The formation of extracellular DNA traps in
cardiovascular diseases
Several non-microbial stimuli for NETs have been
described including cholesterol, which can trigger and
amplify sterile inflammation109. Such stimuli likely play a role
in NET formation associated with cardiovascular diseases.
NETs in atherosclerosis
The presence of NETs has been reported in mice and
human atherosclerotic lesions. Using a two photon micro-
scopic intravital approach, luminally adhering neutrophils
releasing DNA in apolipoprotein-deficient (Apoe−/−) mice
fed a high-fat diet for 4–6 weeks were observed, whereas no
neutrophil adhesion and hence no NET release were
detected in mice receiving chow diet110. Together with
NETs, associated antimicrobial peptide Cramp/LL-37 and
plasmacytoid dendritic cells (pDC) have been identified in
atherosclerotic lesions. Cramp/DNA complexes can sti-
mulate pDC to produce IFN-α, that in turn promotes
atherosclerotic plaque growth that is associated with
enhanced anti-dsDNA antibody titers111. In order to study
atherosclerosis in the absence of NETs, Apoe−/− mice
lacking NE and PR3 (Apoe−/−Elane−/−Prtn3−/−) were
employed and revealed reduced lesions size after 8 weeks of
high-fat-diet feeding112.
Inhibition of PAD4 by Cl-amidine resulted in decreased
atherosclerotic lesion size and delayed carotid artery
thrombosis in the Apoe−/− mouse model80. The authors
also showed that PAD4 inhibition mitigates arterial IFN-I
responses, and reduces the number of netting neutrophils
that infiltrate the media and adventitia of atheromatous
lesions. Although the authors concluded a causative role
for NETs in the development of murine atherosclerosis80,
it should be again noted that a requirement for PAD4 for
NET formation, and its correlation with diseases, is in
dispute17,19,42–45. In fact, more recently, selective genetic
deficiency of Pad4 in bone marrow-derived cells exhibited
no differences in the formation and progression of
atheromatous plaques compared with control mice113.
In mice, cholesterol accumulation in myeloid cells
activates the NOD-like receptor protein (NLRP3)
inflammasome which enhances neutrophil accumulation
and NETs formation in atherosclerotic plaques114. Fur-
thermore, activated platelets were determined as physio-
logical stimulus that via P-selectin induce NET
formation115.
Do these findings obtained in murine models correlate
with human disease? In patients with coronary artery
disease (CAD) proven by CT-angiography markers of cell
death, NET formation in plasma was measured, revealing
significantly elevated levels of dsDNA, nucleosomes, and
MPO–DNA complexes116. Moreover, a high plasma
nucleosome level was identified as an independent risk
factor for severe coronary stenosis, and the level of
MPO–DNA complexes predicted the number of athero-
sclerotic vessels116. In patients with stable coronary artery
disease who had high dsDNA plasma levels, the risk of
experiencing a clinical endpoint defined as unstable
angina, non-hemorrhagic stroke, myocardial infarction, or
death was significantly increased after 2 years117. How-
ever, it still remains to be established whether circulating
extracellular DNA in patients indeed reflects the extent of
NET formation. Nevertheless, host DNases prevented
vascular occlusion by NETs118.
NETs in atherothrombosis
Progression of atherosclerotic lesions can eventually
lead to the destabilization of plaque with subsequent
intraluminal atherothrombosis resulting in acute coronary
syndrome or ischemic stroke, depending on the plaque
location. For initiating arterial thrombosis in injured
vessels, the interaction of neutrophils with endothelial
cells is a critical step preceding platelet accumulation119.
Activated lesional smooth muscle cells (SMCs) may
attract neutrophils that undergo neutrophil death (not
NET formation), releasing nuclear proteins, including
histone H4, which induce lytic cell death of smooth
muscle cells causing the destabilization of plaques. Neu-
tralization of histone H4 led to a plaque stabilization,
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whereas blocking histone H2A or disrupting DNA
structures by DNase had no effect on smooth muscle
cells120. A significant decrease in infarction size and
reduction of citrullinated histone 3 in infarcted tissue
were demonstrated upon blocking of CCL5 and CXCL4 in
mice, what was believed to be due to a reduced neutrophil
recruitment121. In a model of myocardial infarction,
Pad4−/− mice were significantly protected from, whereas
mice without PAD4 deficiency had myocardial injury with
the presence of citrullinated histone H3 at the site of
injury and increased plasma levels for nucleosomes122.
Our interpretation of these findings is that a lytic neu-
trophil death might be prevented in the absence of PAD4.
Therefore, a lytic neutrophil death and not of NET for-
mation seems to be important for atherothrombosis.
On the other hand, studies investigating athero-
thrombosis in humans revealed evidence for the presence
of NETs in thrombi after endarterectomy. NETs were
identified by immunohistochemical staining, e.g., with
anti-MPO and anti-NE antibodies, in fresh and lytic, but
not in organized thrombi. The presence of NETs was
evident in the thrombi and hemorrhages as well as at the
thrombus-plaque interface and in perivascular tissue
adjacent to complicated, but not intact plaques123. In
coronary thrombi, the NET burden was found to correlate
with the infarct size and was negatively related to plasma
DNase activity124. In addition to neutrophils, also mac-
rophages, eosinophils, and mast cells have been observed
to form DNA traps in coronary thrombi125.
NETs in venous thrombosis and thromboembolism
Deep vein thrombosis (DVT) has been linked to neu-
trophil activation and release of NETs based on studies
investigating the pathogenic role of NETs in the patho-
genesis of venous thromboembolism (VT) using geneti-
cally modified mice, various large animal models and
human material assessing plasma markers or thrombi
species126.
In a mouse DVT model applying intravital microscopy,
neutrophils and monocytes, crawling along and adhering
to the venous endothelium, have been shown to provide
the initiating stimulus for DVT127. A cooperative signal-
ing of P-selectin glycoprotein ligand (PSGL)-1 and
CXCR2 in neutrophils increases their adhesion and
enhances murine venous thrombosis through NET for-
mation in flow-restricted veins128. Furthermore, platelet-
derived HMGB1 as well as NK cell-dependent IFN-γ
production were also reported to stimulate NET forma-
tion and thus contribute to the development of thrombi in
deep vein thrombosis129,130. Thrombus-resident neu-
trophils bind factor XII and activate it through the release
of NETs, whereas disintegration of NETs protected
against DVT amplification127. In mice with DVT induced
by flow restriction in the inferior vena cava, extracellular
DNA was increased in plasma, and citrullinated histone
H3 associated with neutrophils in venous thrombi131.
Both the DNA scaffold and histones were shown to
contribute to DVT131.
The analysis of 16 thrombi from patients with VTE
demonstrated that NETs, defined as extracellular diffuse
citrullinated histone 3 areas associated with MPO and
DNA, were predominantly detected during the phase of
thrombus organization, while NETs were rare in unor-
ganized and organized thrombi122. As biomarkers of
DVT, extracellular DNA and MPO have been tested.
Plasma DNA levels are elevated in patients with DVT
correlating with C-reactive protein, D-dimer, von Will-
ebrand factor, and MPO132. Moreover, in elderly patients,
levels of circulating extracellular DNA correlated with the
extent of venous thromboembolism, inflammation as
assessed by C-reactive protein and leukocytosis, and
predicted mortality133. Recently, flow cytometric detec-
tion of MPO/citrullinated histone 3-positive neutrophils
and serum dsDNA have been proposed for biomarker
assessment30. However, as mentioned earlier, these bio-
markers are not suitable for the definition of NET for-
mation and can also not be used for mechanistic studies.
To date, clinical trials investigating whether targeting
NETs prevents or treats venous thrombosis in humans are
lacking. However, some established therapies of venous
thromboembolism may affect extracellular DNA traps126.
For instance, heparin was shown to dismantle the DNA
scaffold and remove platelet aggregates from NETs134.
Acetylsalicylic acid prevents NET formation in vitro by
reducing the phosphorylation of the NF-κB
p65 subunit135. In mice, acetylsalicylic acid inhibited tis-
sue factor activity and NET formation followed by a
marked reduction of thrombus size136. Clopidogrel, by
decreasing P-selectin expression in platelets, blocks the
interaction with neutrophils and thus NET formation137.
The formation of extracellular DNA traps in cancer
Hypothetically, NETs could have anti-tumorigenic
effects, for example by actual killing of tumor cells or
activating the immune system. However, there is more
experimental evidence for a pro-tumorigenic activity of
NETs (Fig. 4). First evidence of NET formation by tumor-
associated neutrophils came from a histopathological
analysis of diagnostic biopsies from Ewing sarcoma. Out
of eight tissue samples, tumor-associated neutrophils
were detected in six and NETs in two patients. In this
study, NET formation was associated with relapsing and
metastatic disease despite chemotherapy138.
In several mouse models, NET formation has been
demonstrated to be associated with tumor growth and/or
metastasis (Fig. 4), e.g., NETs have been reported to
enhance the growth of melanoma139, gastric cancer140,
and hepatocellular cancer141. Moreover, cancer cells
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themselves are able to stimulate neutrophils to form
NETs that facilitate cancer cell migration and invasion as
shown in vitro and in vivo, indicating that they make use
of a physiological host defense mechanism process to
promote metastasis (Fig. 4)142. Mechanisms by which
cancer cells may stimulate neutrophils to form NETs are
the production of IL-8 and the release of exosomes
requiring additional priming with granulocyte colony
stimulating factor (G-CSF) (Fig. 4)142,143. More recently, it
was reported that anaplastic thyroid cancer (ATC) cells
induce the release of mitochondrial extracellular DNA
traps by viable neutrophils. ATC conditioned medium
(CM)–primed neutrophils promoted ATC cell prolifera-
tion in a NET-dependent manner144. Furthermore, tumor
cells have been demonstrated to produce IL-8, attracting
myeloid-derived suppressor cells (MDSC) and activating
granulocytic MDSC to extrude DNA nets145. In addition,
by applying intravital microscopy, a significant increase in
the in vivo hepatic adhesion of intrasplenically injected
lung or colon cancer cells was observed in the presence of
NETs when compared with animals, in which NET for-
mation had been prevented146. Although tumor-
infiltrating neutrophils were rare in tissue specimens of
epithelial ovarian cancer, both intact neutrophils and
NETs were observed in tumors from 4 of 5 patients147.
Moreover, in ascites supernatants of patients with
advanced tumors, high mtDNA, and NE levels were found
that correlated with reduced progression-free survival148.
In order to investigate the association of severe post-
surgical infection and adverse oncologic outcome, a
murine model of infection using cecal ligation and
puncture was applied, demonstrating microvascular NET
deposition and trapping of circulating lung carcinoma
cells that was associated with increased formation of
hepatic metastases following tumor cell injection149.
Similarly, surgical stress employing liver ischemia reper-
fusion resulted in an increase in NET formation with
subsequent development and progression of metastatic
disease, while pretreatment of mice with topical DNase
application or a PAD4 inhibitor abrogated these effects150.
Consistent with the observation in mice, increased post-
operative NET formation inversely correlated with
disease-free survival times in a cohort of patients under-
going attempted curative liver resection for metastatic
colorectal cancer150. It should be noted, however, these
authors measured serum levels of MPO–DNA complexes
and did not directly analyze NET formation. Therefore, it
could very well be that metastasis was associated with
neutrophil cell death and not with NET formation.
Cancer cells remain dormant for a long time. In a
mouse model of lung inflammation induced by either
tobacco smoke or lipopolysaccharide, NET formation was
shown to be essential for awakening dormant cancer cells.
NETs facilitated the contact of associated proteases NE
and MMP9 with their substrate laminin (Fig. 4), resulting
in the cleavage of laminin and revealing an epitope that
activated integrin-mediated signaling and thus prolifera-
tion of dormant cancer cells151.
Conclusion
A beneficial role of NETs and EETs is undisputable, as
several studies have demonstrated its antimicrobial
activities. On the other hand, they might be able to trigger
additional immune responses. Based on recently pub-
lished work, extracellular microbial killing and phagocy-
tosis act in synergy to effectively remove intracellular and
extracellular pathogens regardless of their sizes. A simple
biomarker that reflects NET and/or EET formation is
currently not available. However, extracellular DNA traps
can be detected in inflamed tissues using fluorescence/
immunofluorescence techniques. The mechanism of
Fig. 4 Role of extracellular traps in cancer and metastasis.
Interactions between tumor cells and neutrophils determines the
outcome of tumor growth, progression, and metastasis. Soluble
factors and inflammatory mediators such as IL-8 and granulocyte
colony-stimulating factor (G-CSF), as well as microparticles released
from tumor cells prime and activate neutrophils to form NETs. NETs-
associated granule proteins can contribute to tumor metastasis by
releasing proteases such as matrix metalloproteases (MMPs) and
neutrophil elastase (NE) that allows tumor cells to move out of the
primary niche and to migrate to other organs143,151,160.
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extracellular DNA trap formation remains highly con-
troversial that includes questions regarding the require-
ment of cell death, the source of DNA, as well as
intracellular signaling pathways.
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